Medindia

X

Xeomin(R) Data to be Presented at the 2010 American Academy of Neurology Annual Meeting in Toronto

Tuesday, April 13, 2010 General News J E 4
Advertisement

Efficacy of NT 201 (Botulinum Neurotoxin Type A Free from Complexing Proteins) in the Treatment of Patients with Focal Dystonia

P01.268 - Poster Session I: Movement Disorders: Dystonia I, April 13, 7:30 a.m.

Safety and Efficacy of Repeated NT 201 (Botulinum Neurotoxin Type A Free from Complexing Proteins) Injections of Patients with Cervical Dystonia: A First Long-Term Safety Analysis

P01.270 - Poster Session I: Movement Disorders: Dystonia II and Tardive Dyskinesia, April 13, 7:30 a.m.

Presence of Neutralising Antibodies in a Patient Population with Cervical Dystonia Prior to Clinical Study Entry

P01.271 - Poster Session I: Movement Disorders: Dystonia II and Tardive Dyskinesia, April 13, 7:30 a.m.

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Public Forum: Professional Coalition Panel Speaks ...
S
Leatherby Entrepreneurship Center at Chapman Unive...